Current treatment patterns in non-melanoma skin cancer across Europe
- 1 January 2003
- journal article
- research article
- Published by Taylor & Francis in Journal of Dermatological Treatment
- Vol. 14 (sup3) , 3-10
- https://doi.org/10.1080/jdt.14.s3.3.10
Abstract
With marked increases in the annual incidence of non-melanoma skin cancer (NMSC) across the globe, its management is of increasing concern to dermatologists. This paper summarises the epidemiology and risk factors and provides an overview of treatment approaches in NMSC across Europe, including surgery, topical 5-fluorouracil and cryotherapy, in the context of the trade-offs that exist in finding optimal treatment outcomes. The paper will also briefly examine new approaches such as immunomodulators and the growing body of data on photodynamic therapy (PDT) using methyl aminolevulinate (MAL), including the authors' personal experience of the efficacy and cosmetic results obtained with these newer therapies.Keywords
This publication has 18 references indexed in Scilit:
- Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: Results of a prospective randomized multicenter trialJournal of the American Academy of Dermatology, 2003
- A Randomized, Double-blind, Vehicle-Controlled Study to Assess 5% Imiquimod Cream for the Treatment of Multiple Actinic KeratosesArchives of Dermatology, 2002
- Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: A double-blind, randomized, vehicle-controlled study*Journal of the American Academy of Dermatology, 2002
- From actinic keratosis to squamous cell carcinomaBritish Journal of Dermatology, 2002
- New Treatment Modalities for Basal Cell CarcinomaPublished by Springer Nature ,2002
- A follow-up study of recurrence and cosmesis in completely responding superficial and nodular basal cell carcinomas treated with methyl 5-aminolaevulinate-based photodynamic therapy alone and with prior curettageBritish Journal of Dermatology, 2001
- Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: Results of a multicenter 6-week dose-response trialJournal of the American Academy of Dermatology, 2001
- Guidelines for the management of basal cell carcinomaBritish Journal of Dermatology, 1999
- Comparison of treatment modalities for basal cell carcinomaClinics in Dermatology, 1995
- A Comparison of the Efficacy and Safety of Jessner's Solution and 35% Trichloroacetic Acid vs 5% Fluorouracil in the Treatment of Widespread Facial Actinic KeratosesArchives of Dermatology, 1995